• Go to content
  • Go to search
  • Go to menu
République Française. Liberté, Égalité, Fraternité.
Site de l’ANRS, Maladie infectieuses émergentes — Inserm
  • Newsroom
  • Publications
  • Press room
  • Participant area
  • Français
  • English
Submit a project
  • Who are we?
    Who are we?

    ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.

    • The agency in brief

      A central role in infectious diseases research for over 35 years

    • Mission and strategy

      Supporting research to prevent, understand and treat infectious diseases

    • Leading, funding and structuring research

      ANRS MIE three majors levels of action

    • Organisation and governance

      ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.

    • Scientific commitments and values

      Patient associations, next generation of scientists, quality and ethical approach, open science

    • Emergence programme

      Exceptional procedure for responding to emerging or re-emerging epidemics

  • Research
    Research

    Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.

    • Diseases and pathogens

      Learn more about the diseases and pathogens covered by our research

    • Research projects

      Information on the projects we fund

    • Scientific facilitation groups

      Our workgroups bring together researchers and representatives of civil society

    • Innovation Committee

      Guiding and advising innovative project leaders

  • Infrastructures
    Infrastructures

    The agency supports a number of research platforms and networks to federate and help shape research in its field

    • Research platforms

      National and international research platforms supported by the agency and designed for the scientific community

    • Thematic networks

      Clinical research networks and networks of young researchers

    • Data and samples

      Access to data and biological collections from research promoted by the agency

  • Partnerships
    Partnerships

    The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives

    • The ANRS Emerging infectious diseases International Network

      Partner sites, international global health research platforms, ad hoc partnerships

    • Partnerships and initiatives

      WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks

    • International structuring projects

      Strategic international projects and capacity-building programmes

    • WHO filovirus CORC

      Fighting epidemics: ANRS MIE leads WHO filovirus CORC

    • Patient associations

      Collaboration with community stakeholders

  • Funding
    Funding

    Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players

    • All calls for proposals

      Agency's current, forthcoming and completed calls for proposals

    • Winning projects and candidates

      Find out the list of calls for projects previously funded by the agency

    • Start programme

      Find out the Start programme, here to support and guide the next generation of scientific researchers

    • Avian Influenza A (H5N1) Emergence Unit
    • Filovirus Emergence unit
    • Chikungunya Emergence unit
    • All Emergence Units
  • Newsroom
  • Publications
  • Press room
  • Participant area
    • Français
    • English

Submit a project

Search

  1. Homepage
  2. All news

All news

Here you can find all the latest news and events relating to our areas of research.

Share:

  • Share on Twitter
  • Share on Linkedin


Format
Diseases
Country
Disciplines
Fields

39 results

Trier par


  • Press release

    ANRS DOXYVAC: final analysis may modify interim results of this trial assessing the effectiveness of meningococcal B vaccination in preventing gonococcal infections – ANRS | Emerging Infectious Diseases will commission an independent audit

    ANRS | Emerging Infectious Diseases will commission an independent audit

    24 May 2023

  • Press release

    New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Bacterial STIs and proven efficacy of the MVA-BN Vaccine Against Mpox

    27 February 2023

  • Press release

    Favipiravir: a preclinical study shows lack of antiviral efficacy against SARS-CoV-2 but potential utility against Zika

    A study by researchers from the French Alternative Energies and Atomic Energy Commission (CEA), Inserm and University Paris Cité, who are part of the Preclinical Studies Group (GEPC)* set up by ANRS | Emerging Infectious Diseases, evaluated the effects of favipiravir on SARS-CoV-2 and the Zika...

    13 February 2023

  • Previous
  • 1
  • ...
  • ...
  • 3
  • 4
  • 5
République Française. Liberté, Égalité, Fraternité.
ANRS, Maladie infectieuses émergentes — Inserm
Pratical information
  • Newsroom
  • Contact us
  • Join us
  • Site map
Legal
  • Legal information
  • Personal data and cookies
  • Accessibility
Newsletter

By subscribing, you agree that the ANRS MIE may use your email address to send you the newsletter.